Mechanism of action of voltage-gated K+ channel antibodies in acquired neuromyotonia

Ann Neurol. 2004 Sep;56(3):440-4. doi: 10.1002/ana.20221.

Abstract

Acquired neuromyotonia (ANM) is associated with antibodies to voltage-gated K+ channels (VGKCs). ANM sera reduce the number of K+ currents in neuronal cell lines, but it is not clear how the antibodies act. Here, we show by using the NB-1 cell line that the reduction in K+ currents by IgG is independent of added complement. IgG Fc and Fab fragments from ANM sera had no effect, but three of four ANM F(ab')2 fragments significantly reduced K+ currents. Thus, cross-linking of the channels by divalent antibodies is likely to be an important mechanism in reducing K+ currents.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Autoantibodies / pharmacology*
  • Cell Line, Tumor
  • Female
  • Humans
  • Immunoglobulin G / metabolism
  • Immunoglobulin G / pharmacology
  • Isaacs Syndrome / immunology
  • Isaacs Syndrome / metabolism*
  • Male
  • Middle Aged
  • Potassium Channels, Voltage-Gated / antagonists & inhibitors
  • Potassium Channels, Voltage-Gated / immunology*
  • Potassium Channels, Voltage-Gated / metabolism*
  • Statistics, Nonparametric

Substances

  • Autoantibodies
  • Immunoglobulin G
  • Potassium Channels, Voltage-Gated